|
| SOCIETY INFORMATION |
| EPHAR EXECUTIVE COMMITTEE (2006 - 2008) | ||
| EPHAR EXECUTIVE COMMITTEE (2004 - 2006) | ||
| EPHAR EXECUTIVE COMMITTEE (1997 - 2002) | ||
| EPHAR STATUES | ||
HISTORY OF EPHAR |
||
EPHAR was founded at the XIth International Congress of Pharmacology in Amsterdam (The Netherlands) in 1990. The foundation was prepared by a steering committee headed by Börje Uvnäs, who described the efforts of the committee, its the composition as well as the considerations and discussions preceeding its establishment in the following report dated May 7, 1990: |
||
| “The
idea of a European union of pharmacologists is not new.
It was up for discussion at least as early as the fifties
and the late Corneille Heymans and myself frequently
discussed the possibility of forming some kind of a
common organisation for European pharmacologists. Since
then the idea has been raised several! times and in fact
been seriously considered at several! group meetings.
However, the enthusiasm has always faded away, mainly I
think due to lack of support from the big national
societies’, that felt self-sufficient and did not
share the small and weaker societies need for increased
international contact. And then came the formation of
IUPHAR. The need for a special European co-ordinating
organisation lost its relevance for some time. However,
time has caught up with the federation idea. Today's
effort to unite European economical and political forces
in competition with the world at large has found its
counterpart in the current formation of European
scientific federations. Since long we have a federation
of biochemists, the physiologists are forming their
federative organisation and we have already a superior co-ordinating
organisation of sorts in the European Union of Societies
of Experimental Biology (EUSEB). I have for many years
had a dream, that a meeting of a European federation be
organised with successful American federation meetings as
models worth copying. Pharmacology has developed into a multifaceted discipline extending from molecular biology at one end to clinical pharmacology at the other. This enormous expansion has taken place during the past 10-20 years and left many of us behind, in ignorance about the necessity of collaborative efforts within all branches of biological sciences in the development and analysis of new drugs. The success in pharmacology will depend on the pharmacologists’ ability to acquire the new knowledge and utilise the new tools available, in the efforts to extend pharmacological research into the new domains conquered within the biological sciences. In other words, our goal is to create new generations of pharmacologists with an analytical and broadminded attitude towards important aspects of modern medical biological sciences. On the initiative of Professor Rodolfo Paoletti representatives for the European national pharmacological societies were invited to Milano for discussions about the possibilities of the formation of a European federation of pharmacologists. Eighteen national societies had sent representatives to the meeting, which took place in Milano February 6, 1988. The discussions resulted in the formation of a Steering Committee of six members. After some replacements during the past years the Steering Committee consists at present of the following seven members: Alasdair Breckenridge, Great Britain Flaminio Cattabeni, Italy Gilles Fillion, France Ove A. Nedergaard, Denmark Rodolfo Paoletti, Italy Hasso Scholz, Germany Börje Uvnäs, Sweden Börje Uvnäs was elected chairman and Flaminio Cattabeni secretary. The Steering Committee should work out tentative statutes and an educational programme for the nearest future. Statutes proposed by the Committee were accepted by a meeting of 19 national delegates in Milano April 8, 1989. At a meeting of the Steering Committee at Mannheim July 26, 1989 it was further decided that a Newsletter be produced by the secretariat in Milano headed by Flaminio Cattabeni. The newsletter should be distributed to ail national societies in Europe informing about the activities of the national societies, international activities of interest to European pharmacologists eye. As a result of the activity of the Steering Committee a first educational symposium was held in Milano on February 7-9, 1990 with the title "Molecular Biology in Pharmacology". This first symposium attracted more than 100 young pharmacologists from all of Europe and was considered a great success. It is my hope that a federation of European pharmacologists will further the development of a European scientific community without national barriers and foster a more intimate relationship between our European national societies and their members. Ultimately a new generation of European pharmacologists will with common efforts fight in the scientific frontlines and make use of current developments to the benefit of pharmacology and the pharmaceutical industry.” |
||
The ideas expressed in this report are still valid. Since its establishment in 1990 the aim of EPHAR was to advance research and education in Pharmacology and related sciences and to promote co-operation between National/Regional Pharmacological Societies in Europe. EPHAR was recognized as an affiliate member of IUPHAR in 1994. In addition, the statutes of EPHAR, approved at its foundation, established that the affairs of the Federation are conducted by a Council, formed by representatives nominated by each Society, and by an Executive Committee. The first President, R. Paoletti (Italy), the first Scientific Secretary, F. Cattabeni (Italy) and the first Executive Committee consisting of 4 personalities were in office until 1997. Members of the first Executive Committee were W.C. Bowman (UK), G. Fillion (France), H. Scholz (Germany), and H.A.J. Struijker-Boudier (The Netherlands). Since 1990, the Federation has sponsored important scientific events. In particular, EPHAR has contributed in the organization of residential Courses with a restricted number of participants (“Molecular Biology in Pharmacology”, Milan, 1990; “Neuroimmunomodulation in Pharmacology”, Paris, 1992; “Electrophysiology in Pharmacology”, London, 1993). Courses are addressed to biomedical scientists willing to improve their knowledge in specific fields of pharmacology and related sciences. Moreover, the Federation has sponsored a number of “EPHAR Lectures” held in occasion of joint meetings of member Societies. The most important scientific events established by the Federation are the EPHAR Congresses. Until now (2004), four such meetings took place in different European countries. They included plenary lectures, symposia, round tables, oral and poster communications devoted to the most recent advances in pharmacology and related sciences and therefore represented the adequate forum for discussing preclinical, clinical and therapeutic data. Particular emphasis was given to the impact of biotechnologies on drug development and to the identification of novel pharmacological approaches to incurable diseases. Sessions were also held on the relationship between science and society in Europe, with particular reference to drug registration, strategies for research funding and training of pharmacologists.
In conjunction with the Congress in
Porto in 2004, a first official Satellite Symposium took
place. It was a meeting of the scientific Serotonin Club.
The topic and motto of the Satellite was “Serotonin
in the CNS and Periphery: Basic Concepts and Clinical
Implications”. |
||
|
|
||
| EPHAR COMMITTEE (2006 - 2008) | ||
|
||
President:
|
Treasurer: |
|
Past President:
|
Scientific Secretary:
|
|
Further Members of the Executive Committee: |
||
Dr. Ulrich FÖRSTERMAN
|
Prof. Michael MULVANY
|
|
Prof. Charis LIAPI
|
Prof. Ana SEBASTIÃO
|
|
Prof. Eeva MOILANEN
|
Prof. Jos F.M. SMITS
|
|
|
|
||
| EPHAR COMMITTEE (2004 - 2006) | ||
President: Prof. Marija CARMAN-KRZAN |
Prof. Juan TAMARGO
|
|
| EPHAR EXECUTIVE COMMITTEE (1997-2002) | ||
Vice-President : Prof. Alan W. CUTHBERT Dept. Med., Level 5, Box 157 Addenbrook's Hosp. Hill Road Cambridge CB2 8QQ UK tel. + 44 / 1223 3368 53 fax +44 / 1223 3368 46 E-mail: awc1000@cam.ac.uk Members : Prof. Marija CARMAN-KRZAN Dept. of Pharmacology Faculty of Medicine University of Ljubljana Korytkova 2 Sl-1000 Ljubljana Slovenia tel. + 386 / 5437 351 fax +386 / 5437 331 E-mail: marija.carman-krzan@mf.uni-lj.si Prof. Manfred GÖTHERT Inst. Pharmacol. Toxicol. University of Bonn Reuterstrassse 2b D-53113 Bonn Germany tel. + 49 / 228 7354 10 fax +49 / 228 7354 04 E-mail: goethert@uni-bonn.de Prof. DimitriyA. KHARKEVITCH Dept. of Pharmacology Moscow Medical Academy 2-6, Bolshaya Pirogovskaya Str. 119881 Moscow Russia tel. + 7 / 095 945 8690 fax +7 / 095 151 1261 E-mail: dak@mmascience.ru |
Prof. Jean SASSARD Dept. Physiol.Pharmacol.Clin. Fac. Pharmacie CNRS UMR 5014 8, Avenue Rockefeller F-69373 Lyon Cedex France tel. + 33 / 4 78777 086 fax +33 / 4 78777 118 E-mail: sassard@univ-lyon1.fr
Secretary : Prof. Maria Pia ABBRACCHIO Dept. Pharmacological Sciences Faculty of Phamacy Via G. Balzaretti 9 I-20133 Milano tel. + 39 / 02 503 18310 fax +39 / 02 503 18284 E-mail: mariapia.abbracchio@unimi.it Prof. Franciscus P. NIJKAMP Dept. Pharmacol./Pathophysiol. Univ. of Utrecht P.O. Box 80.082 NL-3508 TB Utrecht The Netherlands tel. + 31 / 30 2537 353 fax +31 / 30 2537 420 E-mail : F.P.Nijkamp1@pharm.uu.nl |
|
| EPHAR STATUES |
|
1. OBJECTIVES OF THE FEDERATION 2, MEMBERSHIP AND DUTIES OF MEMBER SOCIETIES 3. ADMINISTRATION 4. AMENDMENT TO THE STATUTES 4. LEGAL REPRESENTATION
A fundamental principle governing the work of the Federation of European Pharmacological Societies is that nothing done by, or in the name of, the Federation shall detract from autonomy of any of the participanting societies. The Federation seeks to achieve its objects by the following means: (a) to hold and arrange instructional courses and training programmes in matters connected with pharmacology (b) to facilitate the exchange of scientific information between European pharmacologists by encouraging the holding of joint meetings between European member societies and by other appropriate means, like the periodical European Congresses of Pharmacology. (c) To collect, disseminate information and encourage the participation to important activities organized by member societies. This will include the production of a calender of the National and joint meetings of each European Society. (d) the Federation aims at establishing common standards for basic courses in pharmacology. (e) The Federation aims at encouraging scientific collaboration between member societies by appropriate means.
2. MEMBERSHIP AND DUTIES OF MEMBER SOCIETIES (b) Membership shall be terminated for one of the following reasons:
(c) The Member Societies shall The affairs of the Federation shall be conducted by the Council and by the Executive Committee. (A) COUNCIL (i) The Council is formed by representatives nominated by each Member Society of the Federation. Societies with less than 500 members nominate one representative and Societies with more than 500 members may, if they wish, nominate a second representative. Representatives are nominated for a term of 4 years and can be re-elected only for a second successive term immediately.
(iii) The Council may appoint committees for specific purpose, e.g. meetings , publications, exchange- and educational programmes. (iv) There shall be one Regular Meeting of the Council every two years at the occasion of the EPHAR and IUPHAR Congresses. Additional meetings, called Special Meetings, may be held at the request of the majority of the Executive Committee or of at least 50 % of the members of the Council. (v) Except where explicitly stated otherwise on these Statutes, any matter to be decided by the Council shall be decided by a simple majority vote of those present and voting at a meeting of the Council. (ii) If Council members are elected as members of the Executive Committee, these individuals shall cease to be representatives of their Societies. The latter should nominate substitute members for Council to serve for the remaining term of office. (iii) Each member Society may nominate one candidate to be communicated to the Scientific Secretary two months before the Council meeting. (iv) In its first meeting, the Executive Committee shall elect President, President Elect and Treasurer from their number. The President may appoint a Scientific Secretary, who will participate in the Executive Committee meetings without right of vote. The President shall stay in office for two years. The President Elect shall take over for two additional years within the four year period. In circumstances where the President is unable to act, the responsibility shall be taken by the Past President or the President Elect. All decisions are made by majority vote. (v) When Council elect a new Executive Committee with no members who served previously, the Committee may elect one of the Past Presidents to the Committee for guidance as a non-voting member. (vi) The Executive Committee shall act on behalf of the Council in intervals between regular meetings of the Council. All actions by the Executive Committee must be ratified by the next regular or special meeting of the Council. The Executive Committee shall work in conjunction with the local Organising Committee of the EPHAR meetings, according to the guidelines for EPHAR meetings. (vii) Interim vacancies on the Executive Committee may be filled by the President by appointing the head of the list of un-elected candidates. The individual as appointed shall serve for the rest of the unexpired term. (viii) The Scientific Secretary shall: (ix) The Treasurer shall:
Amendment to the Statutes shall be approved by the Council. Prepared amendments must be sent to the President at least two months before the Council meeting at which they are considered and must be endorsed in writing by at least five official members of the Council. Proposed amendments must be transmitted to all members of the Council at least one month before the Council meeting at which they are to be considered. A three-fifth majority vote of the Council members present and voting shall be required for the adoption of any amendment.
5. LEGAL REPRESENTATION Version of July 4, 2006. |
